Steve M. Sabus

Insider Reports History

Location
San Diego, CA
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steve M. Sabus:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Chief Commercial Officer Stock Options (Right to buy) 220,000 $5,685,614 $25.84 05 Dec 2022 Direct
Turning Point Therapeutics, Inc. SVP & Chief Commercial Officer Common Stock 0 $76.00 17 Aug 2022 Direct
Turning Point Therapeutics, Inc. SVP & Chief Commercial Officer Stock Option (right to buy) 0 17 Aug 2022 Direct

Insider Reports Filed by Steve M. Sabus

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNDX Syndax Pharmaceuticals Inc 05 Dec 2022 1 +$5,596,800 4 Chief Commercial Officer 05 Dec 2022, 15:41
SNDX Syndax Pharmaceuticals Inc 05 Dec 2022 0 $0 3 Chief Commercial Officer 05 Dec 2022, 15:37
/report/000120919122046268-sabus-steve-m-2022-08-17 Turning Point Therapeutics, Inc. 17 Aug 2022 2 -$2,786,692 4 SVP & Chief Commercial Officer 17 Aug 2022, 16:27
/report/000120919122033207-sabus-steve-m-2022-05-31 Turning Point Therapeutics, Inc. 31 May 2022 2 $0 4 SVP & Chief Commercial Officer 01 Jun 2022, 17:02
/report/000120919122033203-sabus-steve-m-2022-05-31 Turning Point Therapeutics, Inc. 31 May 2022 0 $0 3 SVP & Chief Commercial Officer 01 Jun 2022, 16:59